Ptc Therapeutics (PTCT) Amortization - Intangibles (2017 - 2026)

Ptc Therapeutics' Amortization - Intangibles history runs 10 years deep, the most recent figure standing at $11.6 million for Q1 2026.

• In Q1 2026, Amortization - Intangibles rose 204.92% year-over-year to $11.6 million; the TTM figure through Mar 2026 stood at $32.5 million (up 150.08% YoY), while the FY2025 annual figure was $24.7 million, down 59.26% from the prior year.
• Amortization - Intangibles was $11.6 million for Q1 2026 at Ptc Therapeutics, up from $9.3 million in the prior quarter.
• In the past five years, Amortization - Intangibles ranged from a high of $77.2 million in Q4 2023 to a low of $2.9 million in Q2 2024.
• Historically, Amortization - Intangibles has averaged $25.7 million across 5 years, with a median of $23.5 million in 2022.
• The sharpest annual moves came in 2024 and 2026: Amortization - Intangibles plunged 95.71% in 2024, then soared 204.92% in 2026.
• A 5-year view of Amortization - Intangibles shows it stood at $35.8 million in 2022, then jumped by 115.79% to $77.2 million in 2023, then slumped by 95.71% to $3.3 million in 2024, then surged by 182.7% to $9.3 million in 2025, then grew by 23.87% to $11.6 million in 2026.
• The last three Amortization - Intangibles figures came in at $11.6 million (Q1 2026), $9.3 million (Q4 2025), and $7.5 million (Q3 2025), per Business Quant data.